Placental-derived stem cell therapy (Celularity)

N/A

Report date: 2023/01/12 16:08:13

Base Information

Drug NamePlacental-derived stem cell therapy (Celularity)
Drug Alias NameUCB and HPDSCHuman placenta-derived stem cellsUCB + HPDSCHPDSCPSC-100
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapy
Mechanisms of ActionCell replacementsImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHematologic DiseasesHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHuman LongevityCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesHuman LongevityCelgene CorpCelularity Inc
Inactive CompaniesN/A
Active IndicationsHematologic DiseasesHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A